Scarica l'app Stockscreener
7.58
0.26%
-0.02
Dopo l'orario di chiusura:
7.75
0.17
+2.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.60
Aprire:
$7.37
Volume 24 ore:
73,394
Relative Volume:
0.51
Capitalizzazione di mercato:
$258.88M
Reddito:
$21.25M
Utile/perdita netta:
$-16.05M
Rapporto P/E:
-12.43
EPS:
-0.61
Flusso di cassa netto:
$-17.14M
1 W Prestazione:
-1.56%
1M Prestazione:
+0.53%
6M Prestazione:
-12.87%
1 anno Prestazione:
+24.67%
Intervallo 1D:
$7.37
$7.895
Intervallo di 1 settimana:
$7.35
$7.895
Portata 52W:
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Nome
Fennec Pharmaceuticals Inc
Settore
Industria
Telefono
(919) 636-4530
Indirizzo
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Confronta FENC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.58 | 259.57M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-22 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Iniziato | CapitalOne | Overweight |
| 2022-08-08 | Ripresa | Craig Hallum | Buy |
| 2020-06-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Iniziato | Goldman | Buy |
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating - Investing.com India
Can Fennec Pharmaceuticals Inc. (RV41) stock stage a strong rebound this quarterJuly 2025 Fed Impact & AI Forecast for Swing Trade Picks - ulpravda.ru
How Fennec Pharmaceuticals Inc. stock reacts to bond yieldsPortfolio Growth Summary & High Win Rate Trade Tips - ulpravda.ru
Is Fennec Pharmaceuticals Inc. (RV41) stock attractive for growth fundsEarnings Miss & Safe Entry Point Identification - ulpravda.ru
Is Fennec Pharmaceuticals Inc. (RV41) stock a safe buy pre earningsJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Published on: 2026-01-08 23:30:09 - ulpravda.ru
Can Fennec Pharmaceuticals Inc. stock continue upward trendJuly 2025 Update & Weekly High Momentum Picks - ulpravda.ru
(FRX) Investment Performance Report (FRX:CA) - Stock Traders Daily
Positive Signs As Multiple Insiders Buy Fennec Pharmaceuticals Stock - Yahoo Finance
(FRX) Pivots Trading Plans and Risk Controls (FRX:CA) - Stock Traders Daily
Aug Final Week: Is Fennec Pharmaceuticals Inc RV41 stock undervalued by metricsTrade Volume Report & Weekly High Return Stock Forecasts - moha.gov.vn
Is Fennec Pharmaceuticals Inc RV41 a good long term investmentStock Split Announcements & High Profit Portfolio Growth - earlytimes.in
Fennec Pharmaceuticals Inc (TSX:FRX) Slipped Under Its Trend Key Levels Matter - Kalkine Media
(FRX) On The My Stocks Page (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving Average – Here’s Why - Defense World
Aug Opening: Can Fennec Pharmaceuticals Inc RV41 stock stage a strong rebound this quarterPortfolio Gains Summary & Safe Swing Trade Setups - moha.gov.vn
Adherex Technologies (NASDAQ:FENC) Major Shareholder Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Stock - Defense World
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Adherex Technologies (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals Says Southpoint Capital Sold 1 Million Shares - MarketScreener
Southpoint trims stake in Fennec Pharmaceuticals to 8% - MSN
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - The Manila Times
Southpoint Capital Advisors controls 2.7 million common shares, 8% of outstanding common shares of Fennec - MarketScreener
Southpoint Trims Stake in Fennec Pharmaceuticals to 8% - TipRanks
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewswire Inc.
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC) - Seeking Alpha
Is Fennec Pharmaceuticals Inc. stock cheap at current valuation2025 Geopolitical Influence & Reliable Intraday Trade Plans - Улправда
Portfolio Update: How Fennec Pharmaceuticals Inc. stock trades before earningsWatch List & Risk Managed Trade Strategies - Улправда
How Fennec Pharmaceuticals Inc. stock performs after earningsOptions Play & Advanced Swing Trade Entry Alerts - Улправда
Is Fennec Pharmaceuticals Inc. stock recession proofAnalyst Upgrade & Long-Term Safe Return Strategies - Улправда
Can Fennec Pharmaceuticals Inc. (RV41) stock hold up in economic slowdownIPO Watch & Comprehensive Market Scan Insights - Улправда
(FRX) Equity Trading Insights (FRX:CA) - Stock Traders Daily
(FENC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Fennec Pharmaceuticals (TSX:FRX) Operate Today In Precision Oncology - Kalkine Media
(FRX) Equity Market Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals Earnings Notes - Trefis
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,061,087.30 in Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,799,524.00 in Stock - MarketBeat
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
Fennec Pharmaceuticals Announces Private Offering to Bolster Financial Position - MSN
(FRX) Risk-Controlled Trading Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals supports new trial for hearing loss prevention in cancer treatment - MSN
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Pfizer (PFE) - The Globe and Mail
How To Trade (FRX) (FRX:CA) - Stock Traders Daily
Stocks in play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Announces Trial Investigating Pedmark to Prevent Hearing Loss in Adult Men - marketscreener.com
Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):